GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.93756 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.93756 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, AKR1B1, ALOX15, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, EGFR, F10, F3, FABP3, FABP4, FLT3, GPR35, HSD17B1, HSPA1A, INSR, KDR, MET, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.54765 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.609 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.58393 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.58393 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, CSNK2A1, CYP1B1, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.96356 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, PPARA, SMAD3, SRC, TEK |
6.66509 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.45799 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, DRD1, EGFR, FABP3, FLT3, IGF1R, INSR, PPARA, SMAD3, SRC, TEK |
6.22306 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, EGFR, F10, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.03747 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, ALOX15, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, FUT7, HSD17B1, MET, PPARA |
5.99647 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, ALPL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, PPARA, SMAD3, SRC, TEK |
5.91433 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, INSR, PPARA, SRC, TEK |
5.59964 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, CYP1B1, EGFR, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MET, SRC, TEK, XDH |
5.5025 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX15, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, HSPA1A, PPARA, XDH |
5.5025 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ALOX15, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, EGFR, F10, F3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TEK |
5.5025 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, CSNK2A1, CYP1B1, EGFR, F10, F3, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.44337 |
[BP] GO:0030335 |
positive regulation of cell migration
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
5.42641 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, ALOX15, ALPL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.4129 |
[BP] GO:2000147 |
positive regulation of cell motility
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
5.29439 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
5.19509 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, CSNK2A1, CYP1B1, DUSP3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, XDH |
5.19345 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.13434 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX15, ALPL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DUSP3, EGFR, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.10346 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.10346 |
[BP] GO:0040017 |
positive regulation of locomotion
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
5.09598 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, ALOX15, CSNK2A1, CYP1B1, DUSP3, EGFR, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.07959 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, AKR1B1, ALOX15, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.04949 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, CYP19A1, DUSP3, EGFR, F3, FABP4, HSPA1A, IGF1R, MET, MMP12, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, XDH |
5.03961 |
[BP] GO:0046777 |
protein autophosphorylation
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, SRC, TEK |
5.03657 |
[BP] GO:0030334 |
regulation of cell migration
|
CYP19A1, CYP1B1, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
5.03657 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX15, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DUSP3, EGFR, F10, F3, FABP3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.94953 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, FABP3, FABP4, FUT7, MET, PPARA |
4.84446 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
4.82313 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, CSNK2A1, DRD1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPRS, SRC, TEK, TNKS, XDH |
4.79802 |
[BP] GO:2000145 |
regulation of cell motility
|
CYP19A1, CYP1B1, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.75662 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
4.7469 |
[BP] GO:0048513 |
animal organ development
|
ACHE, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, FLT3, INSR, KDR, PPARA, PTPRS, SMAD3, SRC, TEK |
4.64091 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
EGFR, F10, F3, INSR, MET, SRC, TEK |
4.54994 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, CSNK2A1, DRD1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPRS, SRC, TEK, TNKS, XDH |
4.52811 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.46309 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FLT3, SRC, TEK |
4.46309 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, CSNK2A1, CYP1B1, EGFR, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP12, NUAK1, SMAD3, SRC, TEK, XDH |
4.46265 |
[BP] GO:0040012 |
regulation of locomotion
|
CYP19A1, CYP1B1, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.43547 |
[BP] GO:0051270 |
regulation of cellular component movement
|
CYP19A1, CYP1B1, DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
4.42696 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, SRC |
4.42696 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FABP3, IGF1R, INSR, PPARA, SRC, TEK |
4.29246 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, SMAD3, SRC |
4.27355 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
4.21909 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CYP19A1, DRD1, EGFR, F3, FABP4, KDR, MET, MMP12, PPARA, PTPRS, SMAD3, TEK |
4.167 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1 |
4.16474 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1 |
4.08992 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EGFR, HSPA1A |
3.95085 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DUSP3, EGFR, F10, F3, FLT3, FUT7, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.92582 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
3.83703 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, CYP1A1, CYP1B1, DRD1, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, SMAD3, SRC |
3.80135 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
CSNK2A1, DRD1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TNKS |
3.69906 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX15, CYP19A1, DRD1, DUSP3, EGFR, HSPA1A, IGF1R, MET, MMP12, PPARA, PTPRS, SMAD3, SRC, TEK, XDH |
3.55528 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, ALPL, CA2, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DUSP3, EGFR, FABP4, FLT3, FUT7, INSR, KDR, MET, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS2 |
3.54347 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, DRD1, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
3.4631 |
[BP] GO:0006468 |
protein phosphorylation
|
CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS |
3.44067 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, DRD1, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
3.42741 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, HSPA1A, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.42572 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, DRD1, EGFR, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
3.42572 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.42572 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.42572 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1 |
3.35695 |
[BP] GO:0051701 |
interaction with host
|
EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.32701 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, CA12, CA2, CA7, DRD1, EGFR, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC |
3.31736 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, AKR1B1, ALOX15, ALPL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, F10, F3, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP12, NUAK1, PPARA, SMAD3, SRC, TEK |
3.17608 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
3.12854 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.12294 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, CSNK2A1, CYP1B1, EGFR, F3, FLT3, HSPA1A, IGF1R, KDR, MET, PPARA, SMAD3, SRC, TEK, XDH |
3.12294 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, NUAK1, SMAD3, SRC |
3.10269 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.06721 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ALOX15, CYP1A1, EGFR, PPARA, SMAD3 |
3.05887 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, ALPL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DUSP3, EGFR, FLT3, INSR, KDR, PPARA, PTPRS, SMAD3, SRC, TEK |
3.0487 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.0006 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
2.94414 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, SRC, TEK, XDH |
2.91958 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
2.91429 |
[BP] GO:0033993 |
response to lipid
|
ALPL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, SRC |
2.91266 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, DRD1, DUSP3, EGFR, GPR35, HSPA1A, IGF1R, MET, MMP12, PTPRS, SMAD3, SRC, XDH |
2.91059 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, DRD1, DUSP3, EGFR, GPR35, HSPA1A, IGF1R, MET, MMP12, PTPRS, SMAD3, SRC, XDH |
2.89986 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1 |
2.89576 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, CA9, CYP1A1, CYP1B1, DRD1, EGFR, FABP3, KDR, SRC |
2.85699 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, CSNK2A1, CYP1B1, EGFR, F3, FLT3, HSPA1A, IGF1R, KDR, MET, SMAD3, SRC, TEK, XDH |
2.85193 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.8149 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.8149 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, CSNK2A1, CYP1B1, DRD1, DUSP3, EGFR, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, NUAK1, PPARA, SMAD3, SRC, TEK, TNKS, XDH |
2.80758 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, ALOX15, ALPL, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.75604 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, EGFR, FABP3, FLT3, IGF1R, INSR, PPARA, SRC, TEK |
2.75256 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.73531 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.71416 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.71336 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, PPARA, SMAD3, SRC, TEK |
2.71336 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
2.69389 |
[BP] GO:0016310 |
phosphorylation
|
CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TNKS |
2.69389 |
[BP] GO:0050678 |
None
|
EGFR, F3, KDR, MMP12, SMAD3, TEK, XDH |
2.68183 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, EGFR, FABP4, HSPA1A, MMP12, PPARA, PTPRS, SMAD3, SRC, TEK |
2.6525 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1 |
2.65088 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, ALOX15, ALPL, CYP19A1, CYP1A2, CYP1B1, DRD1, DUSP3, EGFR, F10, F3, FABP4, IGF1R, INSR, MET, MMP12, PPARA, SMAD3, SRC, TEK, TNKS2 |
2.65088 |
[BP] GO:0032844 |
regulation of homeostatic process
|
CA2, CA7, DRD1, EGFR, KDR, SRC, TNKS, TNKS2 |
2.62858 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, DRD1, EGFR, TNKS, TNKS2 |
2.61028 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ALOX15, CA2, CA7, CYP19A1, DRD1, EGFR, GPR35, HSPA1A, INSR, MMP12, PPARA, SMAD3, SRC |
2.60919 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.59218 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.59064 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, IGF1R, INSR, PPARA, SRC, TEK |
2.57976 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, CSNK2A1, DRD1, EGFR, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.57532 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, DRD1, EGFR, FLT3, SRC |
2.56982 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, EGFR, FABP3, FLT3, IGF1R, INSR, PPARA, SRC, TEK |
2.55107 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
2.51768 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.49978 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, HSD17B1 |
2.46522 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, CYP1B1, DUSP3, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.46522 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, CSNK2A1, DRD1, EGFR, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.46522 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, EGFR, FLT3, INSR, KDR, SRC, TEK, XDH |
2.46522 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.46522 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.46522 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.46522 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK |
2.45463 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.45313 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4 |
2.44682 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.42405 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, EGFR, INSR, SMAD3 |
2.39663 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALOX15, DRD1, EGFR, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.39654 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, EGFR, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP12, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.39564 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, SMAD3, SRC, TEK |
2.39564 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.3899 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.3899 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.3899 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, CSNK2A1, DRD1, EGFR, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, PPARA, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.38903 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.38903 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.38903 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.38903 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.38903 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, PPARA, SMAD3 |
2.38847 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, DRD1, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, PPARA, SRC, TEK, XDH |
2.38847 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, CSNK2A1, CYP1B1, EGFR, F3, FLT3, HSPA1A, IGF1R, KDR, SMAD3, SRC, TEK, XDH |
2.38786 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, CSNK2A1, DRD1, DUSP3, EGFR, F10, F3, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.37703 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.37165 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CSNK2A1, EGFR, F3, FLT3, IGF1R, INSR, KDR, MMP12, TEK |
2.37064 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX15, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, XDH |
2.32754 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, ALOX15, ALPL, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DUSP3, EGFR, F10, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.32329 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, CSNK2A1, DRD1, DUSP3, EGFR, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.32212 |
[BP] GO:0036211 |
protein modification process
|
ALPL, CSNK2A1, DRD1, DUSP3, EGFR, F10, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.32212 |
[BP] GO:0031399 |
regulation of protein modification process
|
ALOX15, DRD1, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, NUAK1, SRC, TEK, XDH |
2.32212 |
[BP] GO:0016042 |
lipid catabolic process
|
CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.32212 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, CYP1A1, CYP1B1, DRD1, KDR, SRC |
2.3166 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, DRD1, EGFR, FABP3, FLT3, INSR, KDR, SMAD3, SRC, TEK, XDH |
2.3166 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, DRD1, EGFR, FABP3, FLT3, INSR, KDR, SMAD3, SRC, TEK, XDH |
2.3166 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD17B1 |
2.3166 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.3166 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, FABP3, FABP4, MET |
2.30847 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DUSP3, EGFR, KDR, SRC, TEK |
2.30233 |
[BP] GO:0050790 |
regulation of catalytic activity
|
CSNK2A1, DRD1, DUSP3, EGFR, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, NUAK1, SMAD3, SRC, TEK, TNKS, XDH |
2.29063 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.27174 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.27174 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, EGFR, INSR, SMAD3, XDH |
2.27174 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
CYP19A1, DRD1, PPARA, PTPRS, SMAD3, TEK |
2.27174 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F3, FABP4, KDR, MET, SMAD3 |
2.27174 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX15, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1 |
2.25877 |
[BP] GO:0031348 |
negative regulation of defense response
|
CYP19A1, MMP12, PPARA, SMAD3, TEK |
2.25445 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, MET, SMAD3, SRC |
2.25445 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, CYP1B1, DRD1, EGFR, KDR, SRC |
2.25445 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4 |
2.2466 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.2462 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.2462 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.2462 |
[BP] GO:0050679 |
None
|
EGFR, F3, KDR, MMP12, TEK |
2.22332 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1B1, DRD1, DUSP3, EGFR, FABP3, FABP4, GPR35, HSPA1A, IGF1R, KDR, MET, MMP12, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.22144 |
[BP] GO:0009056 |
catabolic process
|
ACHE, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MMP12, SRC, XDH |
2.21272 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, SMAD3, XDH |
2.20467 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, SRC |
2.19637 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.19218 |
[BP] GO:0006775 |
fat-soluble vitamin metabolic process
|
CBR1, CYP1A1, CYP3A4 |
2.19218 |
[BP] GO:0010907 |
None
|
INSR, PPARA, SRC |
2.19218 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, DRD1, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, SRC, TEK, XDH |
2.17684 |
[BP] GO:0050920 |
regulation of chemotaxis
|
CYP19A1, F3, KDR, MET, SMAD3 |
2.16636 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, CA2, CYP19A1, DRD1, EGFR, INSR, MMP12, SMAD3, SRC |
2.15176 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, HSPA1A, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.14872 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, KDR, SMAD3, SRC, TEK |
2.1143 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.1143 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.1143 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, KDR, TEK |
2.1143 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ALOX15, CSNK2A1, DRD1, DUSP3, EGFR, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, NUAK1, SMAD3, SRC, TEK, XDH |
2.11421 |
[BP] GO:0032205 |
None
|
SRC, TNKS, TNKS2 |
2.10893 |
[BP] GO:0045124 |
None
|
CA2, EGFR, SRC |
2.10893 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
CA1, CSNK2A1, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.08042 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, CYP1B1, EGFR, HSPA1A, SRC |
2.06526 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
EGFR, HSPA1A, MET, SRC |
2.06413 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
EGFR, HSPA1A, MET, SRC |
2.06413 |
[BP] GO:0030260 |
entry into host cell
|
EGFR, HSPA1A, MET, SRC |
2.06413 |
[BP] GO:0044409 |
entry into host
|
EGFR, HSPA1A, MET, SRC |
2.06413 |
[BP] GO:0051495 |
positive regulation of cytoskeleton organization
|
ALOX15, HSPA1A, MET, SMAD3, TEK |
2.06366 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EGFR |
2.05104 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, EGFR, KDR, SRC, TEK |
2.04633 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, CA2, CYP1A1, DRD1, EGFR, HSPA1A, PPARA, SMAD3, SRC, TEK |
2.0453 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, CA2, CYP1A1, CYP1A2, EGFR, FABP4 |
2.04316 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
KDR, SMAD3, SRC, TEK |
2.04157 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP3A4 |
2.0038 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
ALOX15, KDR, SMAD3, TEK |
2.00009 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ALOX15, CA2, CA4, CA9, DRD1, DUSP3, EGFR, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PTPRS, SRC, TEK |
3.02645 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.63847 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ALOX15, ALPL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, EGFR, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, PTPRS, SMAD3, SRC, TEK |
2.52624 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ALOX15, ALPL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EGFR, F10, F3, FLT3, FUT7, GPR35, IGF1R, INSR, KDR, MET, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.19218 |
[CC] GO:0016323 |
basolateral plasma membrane
|
CA2, CA4, CA9, EGFR, TEK |
2.13125 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, CA2, CA4, CA9, DRD1, EGFR, INSR, MET, SRC, TEK |
2.11421 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALPL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EGFR, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, TUBB3, XDH |
10.7743 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.7306 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, AKR1B1, ALOX15, ALPL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, F10, F3, FLT3, FUT7, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NUAK1, PTPRS, SRC, TEK, TNKS, TNKS2, TUBB3, XDH |
10.6463 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.96356 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.66509 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, MMP12, PPARA, SMAD3, TNKS, XDH |
6.63751 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.217 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PPARA, SRC, TEK |
6.16733 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.10389 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.72386 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.5025 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.19509 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.54331 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
4.4445 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
4.09313 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PTPRS, SRC, TEK, TUBB3, XDH |
4.09093 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.77743 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.59693 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.54347 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.54347 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
3.36536 |
[MF] GO:0004672 |
protein kinase activity
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
3.22748 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
3.1546 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALPL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, F10, MMP12, NUAK1, PPARA, SMAD3, TNKS, TNKS2, XDH |
2.91266 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX15, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, XDH |
2.88955 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
2.66347 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, PPARA, SMAD3, SRC |
2.63847 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.63847 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, PPARA, SMAD3, SRC |
2.60919 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, SRC, XDH |
2.59218 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.59064 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, MMP12, PPARA, SMAD3, TNKS |
2.58484 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TUBB3, XDH |
2.48037 |
[MF] GO:0016301 |
kinase activity
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
2.43384 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.38903 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.38903 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.38903 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.2462 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.2462 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TUBB3, XDH |
2.19218 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, TUBB3, XDH |
2.19218 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP3A4 |
2.1599 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALPL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F10, MMP12, NUAK1, PPARA, SMAD3, TNKS, TNKS2, XDH |
2.14991 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.1143 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
2.02203 |
[MF] GO:0005021 |
vascular endothelial growth factor-activated receptor activity
|
FLT3, KDR |
2.0038 |